• 476
  • 24
  • 1

Ionis shares fell 7.7% in morning trading

Tiger Newspress2022-01-31

Ionis shares fell 7.7% in morning trading.The company and Pfizer Inc. said they discontinued a program testing an experimental treatment for cardiovascular risk reduction and severe hypertriglyceridemia. The companies said that although the drug, vupanorsen, met the primary endpoint in a Phase 2b study, there was concern about its viability as a treatment for those indications. Pfizer had licensed the drug from Ionis in 2019; those rights have now been returned to the company.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment24

  • Nasbhai
    ·2022-02-01
    Gong Xi Fa Cai!! Huat Huat!!
    Reply
    Report
  • Jess261
    ·2022-02-01
    Okay
    Reply
    Report
  • 74rk
    ·2022-02-01
    ok
    Reply
    Report
  • Jazim
    ·2022-02-01
    Okay
    Reply
    Report
  • koolgal
    ·2022-02-01
    That is negative news for Ionis. Hope they can find a new pathway to increase revenue. 🤔
    Reply
    Report
  • 小牛市
    ·2022-02-01
    Ohh
    Reply
    Report
  • Oyh
    ·2022-02-01
    Ok
    Reply
    Report
  • yani
    ·2022-02-01
    Latest
    Reply
    Report
  • yani
    ·2022-02-01
    Latest
    Reply
    Report
  • Victorhc88
    ·2022-02-01
    Like 
    Reply
    Report
  • Joashua
    ·2022-02-01
    Liked
    Reply
    Report
  • ML808
    ·2022-02-01
    Bad
    Reply
    Report
  • 陈河马
    ·2022-02-01
    Wow
    Reply
    Report
  • SPOT_ON
    ·2022-02-01
    Like n follow 
    Reply
    Report
  • FOMOking
    ·2022-02-01
    like
    Reply
    Report
  • 9448Huat
    ·2022-02-01
    Good👍
    Reply
    Report
  • ALLOYHUAT
    ·2022-02-01
    Like
    Reply
    Report
  • GggSlimeR
    ·2022-02-01
    Do not like my comment 
    Reply
    Report
  • Anni001
    ·2022-01-31
    Please likeThanks 
    Reply
    Report
  • niclam
    ·2022-01-31
    To the moon
    Reply
    Report
 
 
 
 

Most Discussed

 
 
 
 
 

7x24

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email:uservice@ttm.financial